This study analyzes the bone response to zirconia ceramic implants inserted in New Zealand white mature male rabbits. The implants were inserted into the tibia, and each rabbit received 4 implants. All the animals were euthanatized after 4 weeks. A total of 20 implants were retrieved. Implants and surrounding tissues were immediately fixed in 4% paraformaldehyde and 0.1% glutaraldehyde in 0.15 molar cacodylate buffer at 4 degrees C and pH 7.4 to be processed for histology. The specimens were processed to obtain thin ground sections with the Precise 1 Automated System. The slides were observed in normal transmitted light under a Leitz Laborlux microscope. A great quantity of newly formed bone was observed in close contact with zirconia ceramic surfaces; in some areas, many osteoblasts were present directly on the zirconia. Percentage of bone-implant contact was 68.4% +/- 2.4%. Mature bone, with few marrow spaces, was present. Small actively secreting osteoblasts were present in the most coronal and apical portions of the implant. No inflamed or multinucleated cells were present. This study concluded that these implants are highly biocompatible and osteoconductive.

No abstract

No abstract

No abstract

No abstract

The expression of all four ErbB receptors was compared by immunohistochemistry, using receptor-specific polyclonal antisera, in 32 invasive, 11 in situ carcinomas, six benign lesions, and 22 samples of histologically normal mucosa adjacent to specimens of carcinoma originating from oral cavity epithelium. Among invasive and in situ carcinoma, EGFR expression was the most prevalent (in 29/32 and 8/11 cases, respectively) followed by ErbB2 (17/32 and 2/11) and ErbB4 (9/32 and 1/10), while ErbB3 was only detected in invasive tumours (12/32). Specific patterns included invasive tumours with expression of EGFR (8/32) or ErbB4 (1/32) alone, as well as different receptor combinations (EGFR+ErbB2, EGFR+ErbB4, EGFR+ErbB2+ErbB3, EGFR+ErbB2+ErbB4, and all four receptors). Simultaneous expression of three or four ErbB receptors correlated with tumour invasion (p=2.2x10(-4)) and localized in the intermediate epithelial cell layer of well and moderately differentiated tumours. No other significant correlation with clinico-pathological features was noticed. Some benign lesions and histologically normal mucosa adjacent to carcinomas showed weak immunostaining of EGFR (10/28), ErbB2 (4/28) or ErbB4 (3/28). By comparison, overexpression, as indicated by increased staining intensity, was observed in invasive tumours for EGFR (18/32), ErbB2 (8/32), ErbB4 (3/32), and ErbB3 (3/32). Statistical evaluation demonstrated a significant association of EGFR or ErbB2 overexpression with invasive carcinoma when compared with benign lesions and apparently normal epithelium (p=5.2x10(-7) and p=5x10(-3), respectively). Tumour-specific overexpression of ErbB receptors and their co-expression, most frequently involving EGFR and ErbB2, in the same cell layer of neoplastic epithelium, implicate receptor heterodimers in the pathogenesis of oral squamous carcinoma.

In view of the superimposable results between the two therapies, it should be noted that the endodontically treated teeth could be interested by different pathologies while the restoration of the atrophic edentulous ridge with an implant support is predictable when patients comply with correct oral hygiene and when the occlusal loads are axially distributed in implant-protected occlusion.

No abstract